Fingerprint
Dive into the research topics of 'Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically